Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for GVDNY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GVDNY and 80,000+ other tickers.
See exactly how GVDNY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GVDNY and 80,000+ other tickers.
Givaudan S.A., operating through its various subsidiaries, serves the global consumer goods industry as a leading creator, supplier, and vendor of products spanning fragrance, beauty, taste, and wellbeing. The company's operations are distinctly segmented into two primary divisions: Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division specializes in a range of offerings, including high-end perfumes, general consumer goods, essential fragrance ingredients, and innovative active beauty compounds. Meanwhile, the Taste & Wellbeing segment caters to an extensive array of food…
Givaudan SA (GVDNY) Q2 2026 Earnings Call Transcript
Givaudan (OTCMKTS:GVDNY - Get Free Report) and Westlake Chemical Partners (NYSE: WLKP - Get Free Report) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk. Risk and Volatility Givaudan has a beta
Westlake Chemical Partners (NYSE: WLKP - Get Free Report) and Givaudan (OTCMKTS:GVDNY - Get Free Report) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk. Dividends Westlake Chemical Partners pays an annual
Givaudan SA remains rated 'Hold' as its valuation still requires optimistic growth assumptions for fair value. Despite a 40% decline from all-time highs, GVBDF trades above intrinsic value, with DCF suggesting CHF 2,170 versus a current price near CHF 2,700. Organic growth is solid, with like-for-like sales up 5.1% in 2025, but currency headwinds and margin compression persist.
Shares of Givaudan SA (OTCMKTS:GVDNY - Get Free Report) have been assigned a consensus rating of "Hold" from the seven ratings firms that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on